Renewable production of high density jet fuel precursor sesquiterpenes from <i>Escherichia coli</i> by Liu, Chun-Li et al.
 
 
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright 
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
 Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
 You may not further distribute the material or use it for any profit-making activity or commercial gain 
 You may freely distribute the URL identifying the publication in the public portal 
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
  
 
   
 
 
Downloaded from orbit.dtu.dk on: Mar 29, 2019
Renewable production of high density jet fuel precursor sesquiterpenes from
Escherichia coli
Liu, Chun-Li; Tian, Tian; Alonso-Gutierrez, Jorge; Garabedian, Brett; Wang, Shuai; Baidoo, Edward E. K.;
Benites, Veronica; Chen, Yan; Petzold, Christopher J.; Adams, Paul D.; Keasling, Jay; Tan, Tianwei; Lee,
Taek Soon
Published in:
Biotechnology for Biofuels
Link to article, DOI:
10.1186/s13068-018-1272-z
Publication date:
2018
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Liu, C-L., Tian, T., Alonso-Gutierrez, J., Garabedian, B., Wang, S., Baidoo, E. E. K., ... Lee, T. S. (2018).
Renewable production of high density jet fuel precursor sesquiterpenes from Escherichia coli. Biotechnology for
Biofuels, 11, [285]. DOI: 10.1186/s13068-018-1272-z
Liu et al. Biotechnol Biofuels          (2018) 11:285  
https://doi.org/10.1186/s13068-018-1272-z
RESEARCH
Renewable production of high density jet 
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Veronica Benites2,3, Yan Chen2,3, Christopher J. Petzold2,3, Paul D. Adams2,3,4, Jay D. Keasling2,3,4,5,6,7, Tianwei Tan1* 
and Taek Soon Lee2,3* 
Abstract 
Background: Aviation fuels are an important target of biofuels research due to their high market demand and 
competitive price. Isoprenoids have been demonstrated as good feedstocks for advanced renewable jet fuels with 
high energy density, high heat of combustion, and excellent cold‑weather performance. In particular, sesquiterpene 
compounds  (C15), such as farnesene and bisabolene, have been identified as promising jet fuel candidates.
Results: In this study, we explored three sesquiterpenes—epi‑isozizaene, pentalenene and α‑isocomene—as novel 
jet fuel precursors. We performed a computational analysis to calculate the energy of combustion of these sesquit‑
erpenes and found that their specific energies are comparable to commercial jet fuel A‑1. Through heterologous 
MVA pathway expression and promoter engineering, we produced 727.9 mg/L epi‑isozizaene, 780.3 mg/L pental‑
enene and 77.5 mg/L α‑isocomene in Escherichia coli and 344 mg/L pentalenene in Saccharomyces cerevisiae. We also 
introduced a dynamic autoinduction system using previously identified FPP‑responsive promoters for inducer‑free 
production and managed to achieve comparable amounts of each compound.
Conclusion: We produced tricyclic sesquiterpenes epi‑isozizaene, pentalenene and α‑isocomene, promising jet fuel 
feedstocks at high production titers, providing novel, sustainable alternatives to petroleum‑based jet fuels.
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Background
Several microbial platforms have been developed for 
advanced biofuel production [1–3]. The advanced bio-
fuels, derived from higher alcohols, alkanes/alkenes, 
fatty acid esters and isoprenoids, are sustainable energy 
alternatives, with favorable properties and great mar-
ket potential [3–5]. Among these biofuel candidates, 
 C10 and  C15 terpenes (monoterpenes and sesquiterpe-
nes) have been increasingly used as jet fuel alternatives 
for commercial aviation and military purpose because of 
their structures, suitable carbon numbers and reactive 
olefin functionality, which collectively impart low freez-
ing points and high energy densities [6–8]. For example, 
monoterpenes or monoterpenoids, such as pinenes [9], 
linalool [10] and limonene [11] have been used as bio-
synthetic precursors for aviation and missile fuels such 
as JP-10, RJ-4 and Jet A-1. Additionally, the hydrogen-
ated sesquiterpene, farnesane, has been commercialized 
as a blend stock for jet fuel AMJ-700 [12]. Recently, there 
has been significant interest in multicyclic sesquiterpenes 
as next-generation jet fuel substitutes due to their high 
energy density and comparable cetane numbers [13]. For 
example, three sesquiterpenes, thujopsene, α-cedrene, 
and β-cedrene, were hydrogenated to generate a fuel 
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blend with 12% higher volumetric net heat of combustion 
than conventional jet fuel [13].
In the interest of expanding the scope of multicyclic 
hydrocarbons as jet fuel alternatives, we sought to pro-
duce three novel tricyclic sesquiterpenes: epi-isozizaene, 
pentalenene and α-isocomene. These sesquiterpenes 
were primarily identified as antibiotic metabolites [14]. 
Epi-isozizaene and pentalenene are produced by sev-
eral Streptomyces species [15–18], while α-isocomene 
is mainly isolated from plants such as Isocoma wright, 
Berkheya radulu and Matricaria recutita [19–21]. Their 
production and recovery efficiency from the natural 
producers, however, are very low when considering the 
quantity and the purity. In this study, we propose that 
these multicyclic sesquiterpenes can be used as jet fuel 
blending agents. We predict the specific energy of com-
bustion for these three compounds using computational 
approaches and we engineer microbes for the scalable 
production of these jet fuel candidates.
In previous research, the epi-isozizaene (EIZS), pen-
talenene (PentS) and α-isocomene (MrTPS2) synthases 
were identified [22–24], and their in  vitro activities 
on farnesyl diphosphate (FPP) were verified. Despite 
these findings, little has been reported on the synthe-
sis of these sesquiterpenes using conventional indus-
trial hosts, such as S. cerevisiae and E. coli, to achieve 
reasonable product titers. Here, we expressed the three 
sesquiterpene synthases in E. coli separately to pro-
duce epi-isozizaene, pentalenene and α-isocomene. 
We utilized both the endogenous methylerythritol 
phosphate (MEP) pathway and the heterologous meva-
lonate (MVA) pathway for efficient FPP supply in E. 
coli (Fig.  1). We codon-optimized each of the sesquit-
erpene synthases and engineered their promoters to 
boost sesquiterpene production. To reduce production 
costs associated with chemical inducers and to mini-
mize human supervision during fermentation process, 
we developed an inducer-free system for production of 
these sesquiterpenes by introducing previously identi-
fied FPP-responsive dynamic promoters [25]. Finally, 
we introduced the pathway for pentalenene produc-
tion into S. cerevisiae, an important industrial host, and 
demonstrated production levels comparable to those 
achieved using E. coli.
Fig. 1 The heterologous mevalonate (MVA) pathway and the native 2‑C‑methyl‑d‑erythritol 4‑phosphate (MEP) pathway for tricyclic sesquiterpene 
production. The heterologous MVA pathway from S. cerevisiae was overexpressed in E. coli to convert acetyl‑CoA into farnesyl diphosphate (FPP). The 
endogenous MEP pathway consisting of 9 genes condenses pyruvate and G3P and contributes to FPP supplementation. FPP is converted into three 
sesquiterpenes by epi‑isozizaene synthase (EIZS), pentalenene synthase (PentS) and α‑isocomene synthase (MrTPS2). Pathway enzymes are AtoB 
acetoacetyl‑CoA thiolase, HMGS HMG‑CoA synthase, HMGR HMG‑CoA reductase, MK mevalonate kinase, PMK phosphomevalonate kinase, PMD 
mevalonate diphosphate decarboxylase, DXS 1‑deoxy‑d‑xylulose 5‑phosphate synthase, DXR 1‑deoxy‑d‑xylulose 5‑phosphate reductoisomerase, 
ispD 4‑diphosphocytidyl‑2C‑methyl‑d‑erythritol synthase, ipk 4‑diphosphocytidyl‑2‑C‑methyl‑d‑erythritol kinase, ispF 2‑C‑methyl‑d‑erythritol 
2,4‑cyclodiphosphate synthase, ispG 1‑hydroxy‑2‑methyl‑2‑(E)‑butenyl 4‑diphosphate synthase, ispH 1‑hydroxy‑2‑methyl‑butenyl 4‑diphosphate 
reductase, idi IPP isomerase, and ispA FPP synthase. Pathway intermediates are MVA mevalonate, G3P glyceraldehyde 3‑phosphate, MEP 
2‑C‑methyl‑d‑erythritol 4‑phosphate, HMBPP 1‑hydroxy‑2‑methyl‑2‑(E)‑butenyl 4‑pyrophosphate, IPP isopentenyl diphosphate, DMAPP dimethylallyl 
diphosphate, and FPP farnesyl diphosphate
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Results
Energy calculation of hydrogenated multicyclic 
sesquiterpenes
Several tricyclic sesquiterpenes  (C15) have recently been 
reported with cetane numbers and cold properties com-
parable to conventional jet fuels [13]. In addition, the 
rings and the strained structure of these compounds are 
generally considered to contribute to increased volumet-
ric energy density.
To further verify their suitability as jet fuel precursors, 
we calculated the energy of combustion for the hydro-
genated products of three sesquiterpenes epi-isozizaene, 
pentalenene and α-isocomene (epi-isozizaane, pental-
enane, and α-isocomane, respectively) using Gaussian 
09 software by B3LYP method [26]. First, the isodesmic 
reactions were designed to calculate the theoretical 
enthalpy of these hydrogenated compounds. Sequen-
tially, the combustion reaction equation was set to obtain 
the standard enthalpy of formation and specific energy 
of compounds. The detailed calculation methods and 
steps are described in the Additional file 1. The specific 
energies of epi-isozizaane, pentalenane and α-isocomane 
were calculated as 42.584  MJ/kg, 42.609  MJ/kg and 
42.783 MJ/kg, respectively, which is similar to that of the 
commercial jet fuel Jet A-1 (42.80 MJ/kg) [27].
In this calculation, we did not include the changing of 
vaporization enthalpy (ΔvapHm) of water with tempera-
ture. When the heat release of water from gas into liq-
uid is considered, the specific energy of these compounds 
will increase 2.559 MJ/kg (as ΔvapHm (100 °C) = 40.63 kJ/
mol). In summary, the calculated values of combustion 
energy of these hydrogenated sesquiterpenes are high 
enough for these compounds to be promising jet fuel 
candidates.
Verification of tricyclic sesquiterpene production in E. coli
For microbial production of the three jet fuel precursor 
candidates, the sesquiterpene synthases responsible for 
production of these sesquiterpenes were identified in the 
literature. Epi-isozizaene synthase (EIZS) from Strepto-
myces coelicolor [17, 28], pentalenene synthase (PentS) 
from Streptomyces UC5319 [22, 23], and α-isocomene 
synthase (MrTPS2) from Matricaria recutita (chamo-
mile) [20] were selected among those reported ter-
pene synthases, and expressed in E. coli after the gene 
sequences were codon-optimized to generate coEIZS, 
coPentS and coMrTPS2. We compared solubility of these 
codon-optimized enzymes with the original EIZS with-
out codon-optimization as a control. All the terpene 
synthases tested showed clear bands on SDS-PAGE gel 
in the whole cell lysate and supernatant, suggesting that 
they are soluble and well expressed in E. coli (Additional 
file 1: Figure S1).
Escherichia coli has an endogenous isoprenoid path-
way (MEP pathway) that produces FPP, a substrate for 
sesquiterpene synthases, even though the natural level of 
FPP is quite low [29]. To confirm the in vivo activity of 
these three sesquiterpene synthases, we cultured strains 
harboring each plasmid expressing these enzymes under 
control of  Ptrc. A decane overlay was used for in  situ 
extraction of the product, and the collected decane layer 
was analyzed using GC–MS. We found that cultures 
expressing coEIZS and coPentS produced single prod-
ucts which showed fragmentation pattern of epi-isozi-
zaene and pentalenene, respectively (Fig.  2a, b). On the 
other hand, the culture expressing coMrTPS2 produced 
a broad spectrum of compounds, including α-isocomene, 
silphinene, modeph-2-ene, β-isocomene, (-)-(E)-β-
caryophyllene and α-humulene, with α-isocomene being 
the major product (Fig. 2c).
To enhance sesquiterpene production, we increased the 
expression levels of the genes encoding coEIZS, coPentS 
and coMrTPS2 using a stronger inducible promoter 
(Fig.  3). The use of the T7 promoter  (PT7) significantly 
improved biosynthesis of epi-isozizaene and pentalenene 
compared to strains harboring a plasmid with  Ptrc-driven 
terpene synthases, probably due to the increased terpene 
synthase levels. The titers of epi-isozizaene and pen-
talenene improved 11.8- and 2.4-fold to 2.82  mg/L and 
0.45 mg/L, respectively, after 48 h. Interestingly, no sig-
nificant titer improvement was observed for cells harbor-
ing the  PT7-driven α-isocomene synthase; the titer was 
still more than an order of magnitude lower than those of 
pentalenene and epi-isozizaene, which was probably due 
to low enzyme activity of coMrTPS2.
High titer sesquiterpene production using 
the heterologous mevalonate pathway
The native MEP pathway is tightly controlled by endog-
enous regulation and may not supply sufficient FPP 
for high titer sesquiterpene biosynthesis [8]. We have 
observed a generally low production level of sesquiterpe-
nes with the native MEP pathway in E. coli when terpene 
synthases are overexpressed. Previous studies showed 
that terpene production can be dramatically improved by 
introducing a heterologous mevalonate (MVA) pathway 
as the flux to FPP is significantly increased with the het-
erologous pathway [7, 30]. The eight-enzyme MVA path-
way converts acetyl-CoA into FPP [30], and a system in 
which the genes encoding those enzymes are harbored 
on a single medium-copy plasmid (“plasmid 1”) and the 
terpene synthase is harbored on a high-copy plasmid 
(“plasmid 2”) is well established (Fig. 4a) [31].
We first used an inducible promoter system to express 
MVA pathway enzymes and the terpene synthase. We co-
transformed the “plasmid 1” containing MVA pathway 
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Fig. 2 Gas chromatography–mass spectrometry (GC–MS) profile of biosynthetic sesquiterpenes. a Retention time and fragmentation pattern 
of biosynthetic epi‑isozizaene (RT: 7.32 min) [17]. b Retention time and fragmentation pattern of produced pantalenene (RT: 6.56 min) [45]. c 
Retention time and fragmentation pattern of a broad spectrum of products from MrTPS2. The mixed products include silphinene (RT: 6.67 min), 
modeph‑2‑ene (RT: 6.90 min), α‑isocomene (RT: 6.95 min), β‑isocomene (RT: 7.15 min), caryophyllene (RT: 7.25 min), α‑humulene (RT: 7.47 min) [20, 
46]
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genes under IPTG-inducible promoter  (PlacUV5) and 
“plasmid 2” containing the terpene synthase under con-
trol of either  Ptrc or  PT7 into E. coli DH1. This resulted 
in the “inducible” sesquiterpene production systems: 
strain CL1601 and CL1605 for epi-isozizaene production, 
CL1607 and CL1611 for pentalenene production, CL1613 
and CL1617 for α-isocomene production (Table 1).
In general, expression of the MVA pathway resulted 
in considerable production of target sesquiterpenes. As 
shown in Fig.  4, the titers of epi-isozizaene and pental-
enene were significantly increased to 215.8  mg/L and 
221.7 mg/L after 72 h in  Ptrc strains CL1601 and CL1607 
(i.e.,  Ptrc is driving sesquiterpene synthases), respectively, 
compared to those without the MVA pathway. When 
 PT7 was driving the sesquiterpene synthases in strains 
CL1605 and CL1612, the titers increased by 3.2- and 
3.5-fold over those strains under  Ptrc, respectively. For 
α-isocomene biosynthesis, the titer increase achieved by 
swapping terpene synthase promoters was much smaller 
than values observed for epi-isozizaene. The α-isocomene 
titer was 41.8 mg/L in strain CL1613 when  Ptrc was used 
to drive expression of MrTPS2; the titer increased to 
50.2 mg/L in strain CL1617 in which  PT7 drives MrTPS2. 
In general, these results confirm that a heterologously 
expressed MVA pathway is much more efficient in ses-
quiterpene production than the endogenous MEP path-
way. Regarding significant titer improvements observed 
when terpene synthases were driven by  PT7, we reasoned 
that the strong pulling effect by high terpene synthase 
levels driven by  PT7 may provide a driving force for the 
entire pathway by depleting the intermediate metabolite 
as substrates for the corresponding enzymes as well as 
by relieving the inhibition of mevalonate kinase by FPP. 
From the targeted proteomics data (Additional file 1: Fig-
ure S10) and the metabolomics data (Additional file  1: 
Figure S9), we could see that the level of coEIZS in strain 
CL1605 was much higher than that in strain CL1601, and 
the FPP level in strain CL1605 was lower than that in 
CL1601. This negative correlation indicates that the high 
terpene synthase levels achieved by stronger,  PT7-driven 
coEIZS gene expression may significantly rewire pathway 
flux towards the conversion of FPP into epi-isozizaene.
Introduction of the FPP‑responsive dynamic system 
for sesquiterpene production
The overproduction of FPP using an inducible het-
erologous MVA pathway substantially improved ses-
quiterpene titers. Inducible promoters, however, 
cannot regulate the intracellular FPP level in response 
to changes of cell growth or environmental conditions, 
and they may lead to suboptimal intracellular FPP con-
centrations, which can be toxic to cells [25]. In addition 
to the lack of dynamic control, the conventional induc-
ible promoters require both the use of expensive chem-
icals such as IPTG as inducer and human supervision 
for induction timing. These make the inducible systems 
less economically feasible in a working industrial set-
ting. To address these challenges, two FPP-responsive 
promoters  PgadE and  PrstA were previously found to be 
useful in creating an auto-inducible isoprenoid produc-
tion system [25]. The gadE promoter  (PgadE) down-reg-
ulates expression of genes under its control when the 
FPP level is high, while the rstA promoter  (PrstA) up-
regulates gene expression at high FPP levels. Therefore, 
using  PgadE for expression of FPP-producing enzymes 
and  PrstA for expression of FPP-utilizing enzymes 
results in a dynamic system to control FPP levels and 
produce sesquiterpenes at high titers [25]. Guided by 
these findings, we systematically studied the effects of 
 PgadE and  PrstA on tricyclic sesquiterpene production.
We first constructed plasmids expressing each ter-
pene synthase under control of  PrstA and confirmed 
Fig. 3 Sesquiterpene production with MEP pathway. a Epi‑isozizaene production with strains, each harboring plasmid JBEI‑15849, JBEI‑15862 and 
JBEI‑15866. b Pentalenene production with strains, each harboring plasmid JBEI‑15863, JBEI‑15867 and JBEI‑15858, respectively. c α‑Isocomene 
production with strains, each harboring plasmid JBEI‑15864, JBEI‑15865 and JBEI‑15859. Titers of compounds were measured by GC–MS at 48 and 
72 h, and data represent averages of three biological replicates
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their expression by testing terpene production using the 
endogenous MEP pathway. We observed the produc-
tion of 0.54 mg/L epi-isozizaene, 0.19 mg/L pentalenene 
and 0.01 mg/L α-isocomene without adding any inducer; 
these levels are comparable to the production via the 
strain with terpene synthases under IPTG-inducible  Ptrc 
(Fig.  3). Then, the IPTG-inducible MVA pathway was 
co-expressed with each of three terpene synthases under 
control of  PrstA (strains CL1602, CL1608, and CL1614 
for epi-isozizaene, pentalenene, and α-isocomene pro-
duction, respectively). We compared the sesquiterpene 
production of these strains with that from strains with 
terpene synthases under IPTG-inducible promoters  (Ptrc 
and  PT7) (Fig.  4). The specific titers of epi-isozizaene, 
pentalenene, and α-isocomene in strain CL1602, CL1608, 
and CL1614 were 125.9 mg/L, 180.4 mg/L, and 8.4 mg/L, 
respectively. The titers of epi-isozizaene and pental-
enene were slightly lower than those of strains with ter-
pene synthases under control of the IPTG-inducible  Ptrc. 
They were significantly lower than those from strains 
that used  PT7 for terpene synthase expression. It is prob-
ably due to much lower terpene synthase level in the 
strains with  PrstA than those in the strain with  PT7. The 
titers of α-isocomene, however, were not straightforward 
Fig. 4 Sesquiterpene production with the MVA pathway and promoter engineering. a Plasmid architecture. A two‑plasmid system for 
sesquiterpene production. Plasmid 1 contains MVA pathway genes producing FPP from acetyl‑CoA either under a  PlacUV5 (inducible) or an 
FPP‑responsive promoter  PgadE (dynamic) with a medium‑copy origin (p15A) and chloramphenicol resistance gene. Plasmid 2 contains a 
sesquiterpene synthase gene under either  Ptrc,  PT7 or an FPP‑responsive promoter  PrstA with a high‑copy origin (colE1) and ampicillin resistance 
gene. b Epi‑isozizaene production. c Pentalenene production. d α‑isocomene production. Titers of compounds were measured at 24, 48 and 72 h. 
Promoters for both plasmid 1 and plasmid 2 are listed to describe strains as well as strain names in x‑axis. Data represent averages of three biological 
replicates with standard deviation as error bars
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to explain in the same way as α-isocomene producing 
strains show more complex products profile as shown in 
Fig. 2c probably due to the promiscuity of α-isocomene 
synthase. But the general trend could still be explained 
by much lower terpene synthase level in the strains with 
 PrstA than those in the strain with  PT7.
An FPP-responsive promoter  PgadE was introduced for 
the MVA pathway gene expression to build a complete 
dynamic system for sesquiterpene production as previ-
ously reported [25]. We prepared sets of six strains for 
each sesquiterpene synthase by combining two MVA 
pathway plasmids (either IPTG-inducible or FPP-respon-
sive) and three terpene synthase plasmids (under either 
IPTG-inducible  (Ptrc and  PT7) or FPP-responsive  (PrstA) 
promoters) as shown in Table  1; CL1601–CL1606 for 
epi-isozizaene production, CL1607–CL1612 for pental-
enene production, and CL1613–CL1618 for α-isocomene 
production.
In contrast to the IPTG-inducible MVA pathway 
for epi-isozizaene (CL1601, CL1602, CL1605) and 
Table 1 Description of E. coli base strains, plasmids and gene clusters used in this study
Plasmid reference Plasmid name Relevant genotype References
JBEI‑2704 placUV5‑MevT‑MBIS p15A, CmR [44]
JBEI‑2872 pgadE‑MevT‑MBIS p15A, CmR [25]
JBEI‑15857 pTrc99a‑EIZS ColE1(pBR322) ori, AmpR This study
JBEI‑15862 pTrc99a‑coEIZS ColE1(pBR322) ori, AmpR This study
JBEI‑15867 pTrc99a‑coPentS ColE1(pBR322) ori, AmpR This study
JBEI‑15865 pTrc99a‑coMrTPS2 ColE1(pBR322) ori, AmpR This study
JBEI‑15856 pTrc99a‑his‑EIZS ColE1(pBR322) ori, AmpR, his tag This study
JBEI‑15855 pTrc99a‑his‑coEIZS ColE1(pBR322) ori, AmpR, his tag This study
JBEI‑15854 pTrc99a‑his‑coPentS ColE1(pBR322) ori, AmpR, his tag This study
JBEI‑15853 pTrc99a‑his‑coMrTPS2 ColE1(pBR322) ori, AmpR, his tag This study
JBEI‑15849 prstA‑coEIZS ColE1(pBR322) ori, AmpR This study
JBEI‑15863 prstA‑coPentS ColE1(pBR322) ori, AmpR This study
JBEI‑15864 prstA‑coMrTPS2 ColE1(pBR322) ori, AmpR This study
JBEI‑15866 pBbE7a‑coEIZS ColE1(pBR322) ori, AmpR This study
JBEI‑15858 pBbE7a‑coPentS ColE1(pBR322) ori, AmpR This study
JBEI‑15859 pBbE7a‑coMrTPS2 ColE1(pBR322) ori, AmpR This study
JBEI‑15861 pRSLeu2d‑coPentS 2μ ori, pBR322 ori, Leu2d This study
Strain name Description References
CL1601 JBEI‑2704 + JBEI‑15862 This study
CL1602 JBEI‑2704 + JBEI‑15849 This study
CL1603 JBEI‑2872 + JBEI‑15849 This study
CL1604 JBEI‑2872 + JBEI‑15862 This study
CL1605 JBEI‑2704 + JBEI‑15866 This study
CL1606 JBEI‑2872 + JBEI‑15866 This Study
CL1607 JBEI‑2704 + JBEI‑15867 This study
CL1608 JBEI‑2704 + JBEI‑15863 This Study
CL1609 JBEI‑2872 + JBEI‑15863 This study
CL1610 JBEI‑2872 + JBEI‑15867 This study
CL1611 JBEI‑2704 + JBEI‑15858 This study
CL1612 JBEI‑2872 + JBEI‑15858 This study
CL1613 JBEI‑2704 + JBEI‑15865 This study
CL1614 JBEI‑2704 + JBEI‑15864 This study
CL1615 JBEI‑2872 + JBEI‑15864 This study
CL1616 JBEI‑2872 + JBEI‑15865 This study
CL1617 JBEI‑2704 + JBEI‑15859 This study
CL1618 JBEI‑2872 + JBEI‑15859 This study
CL1619 S. cerevisiae EPY300 harboring JBEI‑15861 This study
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pentalenene (CL1607, CL1608, CL1611) production, the 
use of dynamic promoter for the expression of the MVA 
pathway resulted in product titers that were less depend-
ent on the type of promoter driving the terpene synthase 
(Fig. 4b, c). When the IPTG-inducible MVA pathway was 
used, there was a significant improvement in terpene 
production with strains containing the  PT7-driven ter-
pene synthases over strains with  Ptrc or  PrstA driving epi-
isozizaene and pentalenene synthase expression (Fig. 4). 
This suggests that the cyclization of FPP to sesquiterpene 
products by the terpene synthase is the primary bottle-
neck in the pathway, and the activity or expression level 
of terpene synthase is a primary determinant of the titer 
when the IPTG-inducible MVA pathway was used. In 
contrast, when the dynamic promoter was used for FPP 
production via the MVA pathway for epi-isozizaene 
(CL1604, CL1603, CL1606) and pentalenene (CL1610, 
CL1609, CL1612) production, there was smaller fluc-
tuation in terpene production among strains with three 
different promoters driving terpene synthase expres-
sion (Fig. 4b, c). This result makes sense as the dynamic 
promoter  (PgadE) can regulate the MVA pathway gene 
expression and, therefore, the metabolic flux to maintain 
the FPP level balanced. The combination of  PgadE-MVA 
with  PrstA- or  Ptrc-driven sesquiterpene synthase enabled 
the cell to balance FPP production and consumption and, 
therefore, to auto-regulate the levels of this toxic inter-
mediate as proven by the measured intracellular FPP 
levels (Additional file  1: Figure S9). The combination of 
 PT7-driven sesquiterpene synthases with  PgadE-MVA 
also achieved a balanced flux and considerable epi-isoz-
izaene titer, but it is considered mainly due to the high 
expression level of coEIZS (Additional file 1: Figure S10). 
Because the FPP-responsive dynamic system auto-regu-
lates the production pathway in case of FPP depletion or 
FPP over-accumulation, the dynamically controlled sys-
tem can improve sesquiterpene production through bal-
anced FPP levels.
For epi-isozizaene production, three strains with 
dynamically regulated MVA pathway showed compa-
rable titers to the highest producing inducible system 
(CL1605) after 48  h, but their production level at 24  h 
was about half of those with the inducible MVA pathway 
(Fig. 4b). This trend, however, does not apply to pentale-
nene-producing system. For pentalenene production, the 
highest titer was achieved using strain CL1611 which has 
the MVA pathway under control of  PlacUV5 and coPentS 
under control of  PT7. The inducible system with  PT7 driv-
ing the terpene synthase (CL1611) showed a significantly 
higher titer than the other pentalenene strains. With the 
exception of CL1611, the titers at 24  h were more than 
twofold higher in strains with a dynamically regulated 
MVA pathway than in those with the inducible MVA 
pathway. It is an interesting result and probably caused 
by the difference in the activity and the availability of two 
terpene synthases. Since FPP is a toxic intermediate, the 
FPP consumption efficiency by terpene synthase affects 
the balance of the entire pathway as well as the titer. The 
kinetics of EIZS and PentS are not available (and it would 
be out of scope of this work), but the differences in the 
activity and the relative amount of soluble enzyme shown 
in the SDS-PAGE results of these two terpene synthases 
(Additional file 1: Figure S1) would be responsible for the 
different trends in FPP accumulation and production for-
mation in these strains.
Strain CL1609 had the full dynamic system and pro-
duced the second highest pentalenene titer and the 
highest  OD600 (Additional file  1: Figure S8). This indi-
cates more sensitive stress-responsive dynamic regula-
tion in CL1609. The cell growth of CL1610 and CL1612 
(Additional file  1: Figure S7) restricted compound bio-
synthesis. For α-isocomene production, the worst per-
former was strain CL1614 containing  PlacUV5-MVA and 
 PrstA-coMrTPS2, probably due to the low level of ter-
pene synthase expression under weak promoter  (PrstA) 
leading to intracellular FPP accumulation and the MVA 
pathway expression unbalanced. This unbalance was 
avoided in strain CL1615 by the dynamic regulation of 
the MVA pathway under  PgadE, and this strain showed a 
decent level of product. Interestingly, the best producer 
was strain CL1616, which contains the dynamically 
controlled MVA pathway and the IPTG-inducible ter-
pene synthase  (Ptrc-coMrTPS2). A similar system with a 
stronger IPTG-inducible promoter driving the terpene 
synthase (CL1618) showed a comparable titer at 24  h, 
but the production did not improve much after 24  h 
and showed a large standard deviation. These observa-
tions suggest FPP production in CL1618 was not well 
balanced for terpene production. It is possible that the 
initial consumption of FPP by highly abundant terpene 
synthase in the early production stage triggered rapid 
FPP biosynthesis under dynamic promoter  (PgadE). This, 
however, may have resulted in a rapid accumulation of 
FPP and have disrupted the MVA pathway through un-
identified process to halt FPP production. In summary, 
when an inducible promoter  (PlacUV5) drives expression of 
the genes encoding the MVA pathway, we observed that 
the combination with  PT7-driven terpene synthase, which 
is expected to have the highest terpene synthase level, 
achieved the highest sesquiterpene production.
Combinations of the dynamic promoter  (PgadE)-driven 
MVA pathway and gene coEIZS or coPentS driven by 
either inducible or dynamic promoters resulted in rea-
sonably high epi-isozizaene and pentalenene titers 
regardless of terpene synthase promoter strength, 
showcasing the advantages of a dynamic system over 
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an inducible system. Although the fully dynamic sys-
tem containing both FPP-responsive promoters  (PgadE 
and  PrstA) did not lead to the highest production, large 
amounts of sesquiterpenes were still obtained for epi-
isozizaene (549.7 mg/L) and pentalenene (608.5 mg/L).
Omics‑aided evaluation of IPTG‑inducible and dynamic 
promoter systems
We investigated changes in MVA pathway enzyme 
expression and metabolite production in response to the 
dynamic promoters compared to the IPTG-inducible 
system using various omics technologies. We chose epi-
isozizaene production strains with 4 different combina-
tions of promoters (strains CL1601 and CL1604 with 
 Ptrc-coEIZS, and CL1605 and CL1606 with  PT7-coEIZS; 
Table  1) and collected their metabolomics (Additional 
file  1: Figure S9) and proteomics (Additional file  1: Fig-
ure S10) data at six time points over 48 h. The concentra-
tions of acetyl-CoA decreased after 4 h in all four strains, 
and MVA concentrations, which are the highest among 
the pathway metabolites monitored, increased at early 
production phases. MVA levels then slowly decreased in 
all four strains, but MVA concentration reached much 
higher level in strains with  PT7 (CL1605 and CL1606) 
than the other strains before it started to decrease. Inter-
estingly, while the MVA levels in strain CL1605 were 
almost 20 times higher than that in strain CL1601 at the 
late fermentation phase, other metabolites such as Mev-
P, IPP/DMAPP, and FPP showed similar levels in CL1601 
and CL1605. From the proteomics analysis shown in 
Additional file  1: Figure S10, we found that CL1601 
expressed the lowest levels of MVA pathway proteins 
overall among these four strains, which may explain the 
poor production titer observed from this strain. Com-
pared to CL1601, the enzyme levels were significantly 
higher in CL1605. Especially for proteins AtoB, HMGS 
and HMGR, strain CL1605 expressed about 5–10 times 
more enzymes than CL1601. This may explain the mark-
edly higher levels of MVA in CL1605. It is interesting to 
observe that the use of strong promoter  (PT7) for terpene 
synthase gene expression improved both the level of coE-
IZS enzyme as intended and the expression of upstream 
pathway enzymes. In our speculation, this is related to 
the deficiency of FPP in early stage (Additional file  1: 
Figure S9) due to high level of terpene synthase. FPP is 
an essential metabolite for E. coli growth and when the 
strain experiences a deficit of FPP, it pushes the path-
way to produce more FPP for survival. As a result, the 
first three enzymes of the MVA pathway were expressed 
more. However, the next two enzymes (MK and PMK) 
levels remained quite low as previously observed [44] and 
this may have limited the conversion of MVA to the next 
intermediates.
We observed dynamic changes in intracellular 
FPP concentrations from strain CL1604 harboring 
 PgadE-MevT-MBIS (JBEI-2872) and  Ptrc-CoEIZS plasmids 
(JBEI-15862) (Additional file 1: Figure S9F). In this case, 
the FPP level decreased in the first 2 h, increased between 
2 and 6 h, decreased again between 6 and 8 h, then even-
tually kept slowly accumulating in the cell. This observa-
tion is consistent with previous findings [25]. However, 
we did not observe a similar trend in strain CL1606, 
which harbors JBEI-2872 and JBEI-15866 expressing epi-
isozizaene synthase under a strong promoter  (PT7), where 
FPP concentration was constantly maintained at very low 
level. This behavior might have resulted from the strong 
promoter  (PT7) expressing excessive epi-isozizaene syn-
thase, which depleted intracellular FPP in CL1606. The 
low FPP level de-represses  PgadE and makes it behave 
constitutively in CL1606. This is consistent with generally 
higher levels of the first three enzymes, which are directly 
influenced by the promoter strength, in strain CL1606 
over strain CL1604 (Additional file 1: Figure S10).
Large‑scale production, purification and NMR 
characterization of the biosynthetic sesquiterpenes
Epi-isozizaene and pentalenene are not commercially 
available in large quantities. Experimental testing of these 
compounds for jet fuel specification, however, requires 
a large quantity of these compounds. Therefore, it is 
required to demonstrate a larger-scale fermentation of 
these sesquiterpenes producers to achieve this goal. To 
demonstrate scalability and the downstream purifica-
tion process, we performed a large-scale production of 
these jet fuel precursors in 4-L flasks with batch culture 
(TB medium with 0.4% glycerol) using the inducer-free 
dynamic E. coli strains CL1603 and CL1609 for epi-isoz-
izaene and pentalenene, respectively. During large-scale 
production, the cultures were overlayed with 20% nonane 
instead of decane to facilitate sesquiterpene extraction, as 
the boiling temperature of nonane (151 °C) is lower than 
that of decane or dodecane (174.1 °C or 216.2 °C, respec-
tively), which makes it easier to recover the product from 
the overlay by evaporation of the solvent.
About 0.8  L and 0.5  L of nonane were collected from 
the epi-isozizaene biosynthesis cultures and the pen-
talenene biosynthesis cultures, respectively, using a 
separatory funnel. The products were recovered from 
the nonane overlay by a series of purification steps as 
described in “Methods” section. We used NMR to iden-
tify the product and to check its purity (i.e., the specific-
ity of terpene synthase toward the expected product) and 
confirmed these two compounds with the purities over 
90% and assigned their NMR spectra (Additional file  1: 
Figures S2–S5).
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Finally, we prepared about 1  mL epi-isozizaene and 
0.66  mL pentalenene with over 90% purity from large-
scale batch cultures (4 L for epi-isozizaene and 2.5 L for 
pentalenene), which contains 1.08  g epi-isozizaene and 
0.66 g pentalenene. The recovery efficiencies were about 
49% and 43%, respectively, when considering the produc-
tion titer from GC analysis.
Sesquiterpene production in yeast
The Baker’s yeast, Saccharomyces cerevisiae, has been 
the host of choice for industrial production of various 
bio-products and widely used for terpene biosynthesis. 
Therefore, in addition to production in E. coli we sought 
to demonstrate the production of one of these sesquiter-
penes, pentalenene in S. cerevisiae (Fig. 5).
We employed a previously reported host strain engi-
neered for high FPP production (EPY300) [32] (Fig. 5a). 
To efficiently convert FPP to pentalenene, we introduced 
the codon-optimized gene coPentS under the control of a 
galactose promoter on a high-copy plasmid (2 μ) contain-
ing the auxotrophic Leu2d marker, as previously used to 
achieve high levels of amorphadiene [33]. We used both 
defined CSM medium and non-selective, rich, mixed 
carbon YEP medium supplemented with 1.8% galac-
tose/0.2% glucose for culturing the yeast cells. Conse-
quently, higher cell density and production were achieved 
using the rich medium. After 120 h, 344.7 mg/L pentale-
nene was obtained in mixed carbon YEP medium, which 
was 17.5-fold higher than that in CSM medium (Fig. 5b).
Fig. 5 Pentalenene production in S. cerevisiae. a The S. cerevisiae host engineered for the production of antimalarial precursor amorphadiene was 
re‑engineered to produce pentalenene by overexpressing pentalenene synthase (PentS) in a plasmid. ERG10 acetyl‑CoA acetyltransferase, IDI1 
isoprenyl diphosphate isomerase, ERG20 farnesyl disphosphate synthase. Genes in blue arrows (upc2‑1, tHMGR, ERG20 and PentS) are overexpressed. 
b Production titer and c cell growth  (OD600) with CSM medium and YEP medium supplemented with 1.8% galactose/0.2% glucose
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Discussion
In this work, we proposed three tricyclic sesquiterpenes 
as promising jet fuel precursors. The calculated combus-
tion energies of the target sesquiterpenes show positive 
results for their use as jet fuels. Additionally, we engi-
neered microbes to produce these jet fuel precursors 
at high titers to demonstrate the potential of microbial 
jet fuel manufacturing. In particular, we developed an 
inducer-free system using previously identified FPP-
responsive promoters and obtained a respectable amount 
of sesquiterpenes, allowing future application to the 
industrial fermentation process.
The engineered MVA pathway is a very efficient FPP 
supply platform for sesquiterpene biosynthesis and the 
increased FPP flux drives the implementation of FPP-
responsive promoters  (PgadE and  PrstA) to render higher 
production titers by relieving the toxicity from FPP 
accumulation, as previously reported [25]. This dynamic 
setting, however, did not always result in higher titer 
compared to the inducible system (with  PlacUV5 and  PT7 
promoters) used in this study, and this implies that there 
are more factors that affect efficiency of the dynamically 
regulated system and it may require additional adjust-
ment to achieve balanced enzyme expression and opti-
mized pathway performance. Finally, we demonstrated 
the production of one of these sesquiterpenes in S. cer-
evisiae, a microbial host that is widely used for biofuel 
production. Much work including terpene synthase 
enzyme engineering (for a better activity and specificity) 
and culture medium and process optimization (for scale-
up) would be needed to improve the titer, yield, and pro-
ductivity of these sesquiterpenes in S. cerevisiae.
Tricyclic sesquiterpenes are expected to have several 
advantages over the already commercialized acyclic bio-
jet fuel precursor, farnesene (or  Biofene® from Amyris) 
as versatile feedstocks to jet fuels. First, they have higher 
densities than farnesene (around 1.0 g/mL vs 0.81 g/mL 
of farnesene), which deliver higher volumetric net heats 
of combustion [13, 34]. Considering small increases in 
volumetric energy density can have major impacts on 
profitability of airlines, especially for long haul flights, 
higher density fuel would be preferred over lower density 
fuels. Also, while farnesene has four double bonds and 
requires four molar equivalents of dihydrogen to gener-
ate the actual fuel molecule (saturated hydrocarbons, 
farnesanes), tricyclic sesquiterpenes have only one dou-
ble bond and require just one dihydrogen molecule per 
fuel molecule, making the refining process less expensive.
In the past decade, the farnesene biosynthetic pathway 
has been extensively studied and optimized [35–37]. Cur-
rently, a production of $2.2/kg has been achieved and 
the estimated price will become even lower in the near 
future [38]. Since tricyclic sesquiterpenes and farnesene 
share a large portion of their biosynthetic pathways, we 
expect that an engineering strategy similar to that used 
to produce farnesene could be applied to achieve high 
productivity and yield of tricyclic terpenes. In this study, 
we have achieved only about a gram scale production to 
demonstrate the production, isolation, and characteriza-
tion. This amount, however, might be not quite enough 
for any jet fuel specification testing as it requires much 
larger amounts of fuel candidates to test standard jet fuel 
specification such as ASTM D1655. The successful dem-
onstration of the downstream purification processes we 
presented in this report would be a fundamental work for 
producing large quantities of sesquiterpene compounds 
in future. More studies including production scale-up 
will be also needed for further validation of these new jet 
fuel compounds.
Conclusions
Sesquiterpenes and sesquiterpene-derived molecules are 
promising alternatives to aviation fuels. In the present 
study, we proposed tricyclic sesquiterpene compounds, 
epi-isozizaene, pentalenene and α-isocomene as jet fuel 
precursors to expand the scope of bio-jet fuels. The ses-
quiterpene synthases were introduced into E. coli with 
either endogenously or heterologously expressed isopre-
noid pathways, and the production pathway was engi-
neered to increase the product titer. IPTG-inducible and 
dynamically controlled systems were compared for ses-
quiterpene production; proteomics and metabolomics 
analysis of these systems explain the different behaviors 
of various strains. In addition, we generated a yeast strain 
for one of the jet fuel targets, pentalenene, to explore an 
alternate host for large scale fermentation. In summary, 
the engineered strains produced tricyclic sesquiterpenes 
at high titers with 727.9 mg/L epi-isozizaene, 780.3 mg/L 
pentalenene and 77.5  mg/L α-isocomene in E. coli in a 
batch culture with 10  g/L glucose, and 344  mg/L pen-
talenene in S. cerevisiae with YPG medium. The current 
study will provide a solid ground toward sustainable 
alternatives to high energy density fuels for the long-term 
global energy demand.
Methods
Plasmids and strains construction
All plasmids and strains used in this study are available 
on the JBEI public registry (https ://publi c-regis try.jbei.
org) and listed in Table 1 along with a brief description of 
production strains. E. coli DH10B was used for plasmid 
construction, and E. coli DH1 and E. coli DH1 (DE3) were 
used as hosts for terpene production and protein expres-
sion. Plasmids containing eight genes for the mevalonate 
pathway (atoB, hmgs, hmgr, mk, pmk, pmd, idi, ispA) 
were introduced into E. coli host, enabling production 
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of FPP from acetyl-CoA. Five genes (hmgs, hmgr, mk, 
pmk, pmd) originated from S. cerevisiae and three genes 
(atoB, idi, ispA) are native E. coli genes. For sesquiter-
pene production in E. coli, four terpene synthase genes 
[the original EIZS from Streptomyces and three E. coli 
codon-optimized genes, coEIZS, coPentS and coMrTPS2, 
which were amplified from gBlock templates synthe-
sized by IDT (Iowa, USA)] were cloned into pTrc99 at 
NcoI and XbaI sites, to yield the plasmids JBEI-15857, 
JBEI-15862, JBEI-15867 and JBEI-15865, respectively. 
To insert an N-terminal His-tag for protein purification, 
PCR was performed using the primers that included a 
His-tag sequence and the PCR product was cloned into 
pTrc99 vector yielding plasmids JBEI-15856, JBEI-15855, 
JBEI-15854 and JBEI-15853, respectively. Genes coEIZS, 
coPentS and coMrTPS2 were cloned into vector pPrstA-
RFP [25] via the isothermal assembly method [39] using 
a commercial Gibson  Assembly® Master Mix kit (New 
England Biolabs) to yield plasmids prstA-coEIZS, prstA-
coPentS and prstA-coMrTPS2, respectively. Plasmid 
pBbE7a-coEIZS, pBbE7a-coPentS and pBbE7a-coM-
rTPS2 were also constructed using vector pBbA7a-RFP 
between NdeI and XhoI sites. For pentalenene production 
in S. cerevisiae, coPentS was cloned into vector pRSLeu2d 
[31] between the NheI and XhoI sites. All the promoter 
strength was indicated by RFP florescence as shown in 
Additional file 1: Figure S7.
Sesquiterpene production in E. coli
For MVA pathway expression, E. coli DH1 was co-trans-
formed with an MVA pathway plasmid JBEI-2704 (for the 
IPTG-inducible system) or JBEI-2872 (for the dynamic 
system) and a plasmid harboring one of each terpene 
synthase gene. Pre-cultures of E. coli strains were diluted 
1:100 into EZ rich defined medium (Teknova, Hollister, 
CA) containing 10  g/L glucose as carbon source and 
ampicillin (100 µg/mL) and chloramphenicol (30 µg/mL) 
for plasmid maintenance. The cell cultures were grown 
at 37  °C until  OD600 reached ~ 0.6, and induced with 
0.5  mM IPTG while shaking at 30  °C; 20% decane was 
added for in  situ product extraction. At 24  h, 48  h and 
72 h time points, 10 μL of the decane layer was taken and 
diluted into 990 μL of ethyl acetate for GC–MS analysis. 
Caryophyllene was used as an internal standard for the 
production of epi-isozizaene and pentalenene, while pen-
talenene was used as internal standard for the production 
of α-isocomene since the strain with MrTPS2 also pro-
duces detectable amount of caryophyllene.
Detection of sesquiterpenes with GC–MS
The decane fraction from the culture medium was ana-
lyzed by GC–MS (Thermo Trace Ultra with PolarisQ MS) 
with a TR-5MS column (30  m × 0.25  mm ID × 0.25  µm 
film) using the following conditions: inlet at 250  °C, 
1.1 mL min−1 constant flow, transfer line at 300  °C, ion 
source at 200  °C, scan m/z 50–300. Oven: 100  °C for 
4  min, ramp at 30  °C  min−1 to 250  °C, hold for 1  min. 
Samples of 1 μL were injected into the GC. The products 
were analyzed in total ion monitoring mode and selective 
ion monitoring mode (m/z 204).
Large‑scale production, purification, and characterization 
of the biosynthetic sesquiterpenes
For the preparation of sesquiterpene compounds epi-
isozizaene and pentalenene, the E. coli strains for ses-
quiterpene production were cultured at 30  °C for 72  h 
after induction. One liter of Terrific Broth (Difco) with 
4% glycerol was used for batch production in a 4-L flask 
overlayed with 200 mL of nonane to facilitate sesquiter-
pene extraction. The nonane overlay was collected from 
the culture medium using a separatory funnel and dried 
over sodium sulfate. Nonane was evaporated under 
reduced pressure, and the crude sesquiterpenes were 
loaded onto a silica gel column for column chromatog-
raphy using hexanes as the mobile phase. The product 
containing fractions were pooled and the solvent was 
evaporated under reduced pressure. The product was 
obtained as colorless oil and further purified by pre-
parative silver ion thin-layer chromatography (Ag-TLC) 
for nuclear magnetic resonance (NMR) analysis. Sil-
ver nitrate was adsorbed onto thin-layer silica by meth-
ods described previously [40]. TLC plates (500 µm layer 
thickness) were sprayed with an  AgNO3 solution (5% w/v 
in methanol), dried at 110 °C for 10 min and allowed to 
cool at room temperature directly before use. Plates were 
developed in hexane and the pure product was dissolved 
in n-pentane and concentrated under reduced pressure. 
The structure of the isolated epi-isozizaene and pental-
enene dissolved in  CDCl3 was analyzed by 1H and 13C 
NMR using a 500 MHz NMR spectrometer (Bruker DRX-
500). NMR spectrum of biosynthetic epi-isozizaene: 
1H NMR (600  MHz,  CDCl3): δ 2.22 (ddp, J = 17.0, 9.1, 
1.2 Hz, 1H), 2.13–2.03 (m, 1H), 1.83 (dd, J = 7.4, 5.3 Hz, 
1H), 1.80–1.76 (m, 2H), 1.76–1.71 (m, 1H), 1.62–1.54 
(m, 1H), 1.48 (dd, J = 10.5, 5.3 Hz, 1H), 1.43 (t, J = 1.5 Hz, 
3H), 1.40 (d, J = 10.0, 1.9  Hz, 1H), 1.38–1.34 (m, 1H), 
1.26–1.21 (m, 1H), 1.18 (tdd, J = 11.5, 3.4, 2.1  Hz, 1H), 
1.00 (s, 3H), 0.98 (s, 3H), 0.92 (d, J = 6.4 Hz, 3H) (Addi-
tional file 1: Figure S2). 13C NMR (151 MHz,  CDCl3): δ 
143.0, 127.5, 52.7, 47.2, 40.5, 39.7, 37.0, 32.5, 28.7, 28.4, 
27.3, 25.1, 24.4, 14.1, 12.9 (Additional file  1: Figure S3). 
NMR spectrum of biosynthetic pentalenene: 1H NMR 
(600 MHz,  CDCl3): δ 5.15 (h, J = 1.6 Hz, 1H), 2.66 (ddh, 
J = 9.3, 4.5, 2.1 Hz, 1H), 2.54 (d, J = 9.4 Hz, 1H), 1.86–1.80 
(m, 1H), 1.78 (ddd, J = 12.5, 6.1, 3.0  Hz, 1H), 1.73 (dd, 
J = 13.1, 1.0  Hz, 1H), 1.62 (h, J = 1.4  Hz, 4H), 1.37–1.23 
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(m, 4H), 1.18 (ddd, J = 12.5, 5.1, 0.9 Hz, 1H), 0.98 (s, 3H), 
0.98 (s, 3H), 0.90 (d, J = 7.1 Hz, 3H) (Additional file 1: Fig-
ure S4). 13C NMR (151 MHz,  CDCl3): δ 140.5, 129.5, 64.7, 
62.0, 59.3, 48.9, 46.8, 44.5, 40.5, 33.5, 29.9, 29.1, 27.5, 17.0, 
15.5 (Additional file 1: Figure S5).
Metabolite analysis and targeted proteomics
All metabolites were analyzed by liquid chromatogra-
phy–mass spectrometry (LC–MS; Agilent Technologies 
1200 Series Rapid Resolution HPLC system and Agi-
lent Technologies 6210 time-of-flight mass spectrom-
eter (TOF–MS) (Agilent Technologies, Santa Clara, CA, 
USA) on a  SeQuant®  ZIC®-pHILIC column (150  mm 
length, 2.1-mm internal diameter, and 5-µm particle 
size). Targeted proteomics was performed using an Agi-
lent 1290 liquid chromatography system coupled to an 
Agilent 6460 QQQ mass spectrometer (Agilent Technol-
ogies, Santa Clara, CA) via selected reaction monitoring 
(SRM) at the same points of the samples of metabolites. 
The sample preparation and detailed method of metab-
olite analysis and targeted proteomics are presented in 
Additional file 1: Supplementary Methods.
Pentalenene production in S. cerevisiae
Pre-cultures of S. cerevisiae strain harboring the plasmid 
pRsLeu2d-coPentS were used to inoculate at an  OD600 of 
0.05 into 5 mL of Complete Supplemental Mixture (CSM; 
MB Biomedicals, Solon, OH) medium or rich mixed 
carbon yeast extract peptone (YEP; 1% yeast extract, 
2% peptone) medium supplemented with 1.8% galac-
tose/0.2% glucose and overlayed with 10% decane. At 
72 h, 96 h and 120 h, 10 μL decane layer was sampled and 
diluted 100 times into ethyl acetate with caryophyllene as 
the internal standard. For pentalenene quantification, the 
samples were analyzed by GC–MS as described above.
Energy calculation
The thermodynamic parameters of the two compounds 
were calculated by means of density functional theory 
(DFT) method using Gaussian 09 software. All the 
DFT calculations were performed using the hybrid 
B3LYP method with the 6-311+G(2d,p) basis set level 
[26, 41], which can provide a nice balance between 
cost and accuracy, and is known to perform very well 
for the prediction of geometries of compounds. The 
specific energy was calculated following the steps of 
the isodesmic reaction to get the standard enthalpy 
of formation, as well as considering the combustion 
reaction equation to get the enthalpy values of com-
bustion. Isodesmic reactions have been found to be a 
more accurate computational approach than atomi-
zation enthalpy calculations or heat of atomization 
calculations as demonstrated previously in calculating 
enthalpy of formation of formaldehyde [42]. It has also 
been used in other bond energy calculation [43]. The 
detailed calculation methods and steps are shown in 
the Additional file 1: Supplementary Methods.
Additional file
Additional file 1. Supplementary figures and supplementary methods. 
Figure S1: Purification and characterization of sesquiterpene synthases. 
Figures S2 and S3: 1H and 13C NMR spectrum of biosynthetic epi‑
isozizaene. Figures S4 and S5: 1H and 13C NMR spectrum of biosynthetic 
pentalenene. Figure S6: Epi‑isozizaene production in E. coli DH1 via the 
native MEP pathway catalyzed by the epi‑isozizaene synthase. Figure S7: 
The RFP florescence indicating promoter strength. Figure S8:  OD600 of E. 
coli strains for sesquiterpenes production. Figure S9: Metabolite analysis. 
Figure S10: Targeted proteomic analysis of pathway enzymes.
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